Finance

Why you should put everything on these two stocks: Histogenics Corporation (NASDAQ:HSGX) and Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Histogenics Corporation (NASDAQ:HSGX)

Histogenics Corporation (NASDAQ:HSGX) Performance Snapshot

Histogenics Corporation (NASDAQ:HSGX) Price Insight

Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Collegium Pharmaceutical, Inc. (NASDAQ:COLL), closed the last trading session at $21.57 with increase of $0.390000000000001 or 1.84 percent against the opening price of $21.18. The trading day volume of the company stands at 178772 shares while the average trading volume of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) is 279.79 Million over the course of 3 consecutive months. Which signifies a pretty good change over the time with its shares outstanding of 34.54 Million.

The price target of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) is currently set at 27.86 by the analysts. The stock is $-15.71 Below its 1-Year High which is $25.59. COLL hit its 1-Year low price of $13.00. The company is currently rated by analyst who are keeping a close eye on the stock as 2.1. Where 1 means Buy, 2.5 meaning Hold and 5 as Sell.

Performance Indicators of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

The value of the stock increased by 12.08% during the previous week performance. Looking at the 1 month performance of Collegium Pharmaceutical, Inc. (NASDAQ:COLL), the stock jumped 13.41%. While the 1 year performance shows a negative percentage of -10.09 and year to date performance stands at 7.69%.

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Analytical Review

The stock needs to grow about $6.29 to reach its price target. In order to seek the stock’s directional movements, 20-Days, 50 Days and 200-Days moving averages are 9.67%, 11.72% and 13.14 percent respectively. The stock trades about 12.19 percent of its Float giving its total shares Outstanding are 34.54 Million. COLL gained about 29.51 percent in 6 months showing its Average True Range of 1.06. The company currently has a RSI and Beta of 61.51 and 1.08.

While talking about Collegium Pharmaceutical, Inc. (NASDAQ:COLL) valuation ratios, the stock trades with a P/S and P/B of 2.52 and 4.31 which is significantly better and attractive as compared to its peers.

Leave a Reply

Your email address will not be published. Required fields are marked *